KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Egain (EGAN) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Egain (EGAN) over the last 16 years, with Q4 2025 value amounting to -$6000.0.

  • Egain's Asset Writedowns and Impairment fell 40000.0% to -$6000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$15000.0, marking a year-over-year decrease of 10892.86%. This contributed to the annual value of $63000.0 for FY2025, which is 3225.81% down from last year.
  • As of Q4 2025, Egain's Asset Writedowns and Impairment stood at -$6000.0, which was down 40000.0% from $1000.0 recorded in Q3 2025.
  • Egain's 5-year Asset Writedowns and Impairment high stood at $116000.0 for Q1 2021, and its period low was -$162000.0 during Q3 2021.
  • For the 5-year period, Egain's Asset Writedowns and Impairment averaged around $35368.4, with its median value being $71000.0 (2022).
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first surged by 118888.89% in 2021, then crashed by 40000.0% in 2025.
  • Quarter analysis of 5 years shows Egain's Asset Writedowns and Impairment stood at $85000.0 in 2021, then crashed by 80.0% to $17000.0 in 2022, then skyrocketed by 535.29% to $108000.0 in 2023, then crashed by 98.15% to $2000.0 in 2024, then plummeted by 400.0% to -$6000.0 in 2025.
  • Its Asset Writedowns and Impairment was -$6000.0 in Q4 2025, compared to $1000.0 in Q3 2025 and -$10000.0 in Q1 2025.